{
  "docId": "019de514-fe96-71db-bb6e-6cd3aac05812",
  "docSlug": "7af1a9080317648bf46230163ee8ee8d",
  "documentTitle": "G Medical Innovations | IPO Presentation Deck | 29 slides",
  "authorId": "g-medical-innovations",
  "authorName": "G Medical Innovations",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2023-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 21,
  "pageCount": 29,
  "prevPage": 20,
  "nextPage": 22,
  "slideType": "other",
  "function": "present_framework",
  "density": "overcrowded",
  "nDataPoints": 12,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de514-fe96-71db-bb6e-6cd3aac05812/21",
  "deckHref": "/decks/019de514-fe96-71db-bb6e-6cd3aac05812",
  "deckJsonHref": "/decks/019de514-fe96-71db-bb6e-6cd3aac05812.json",
  "deckAnchorHref": "/decks/019de514-fe96-71db-bb6e-6cd3aac05812#slide-21",
  "components": [
    {
      "bbox": {
        "h": 0.07,
        "w": 0.93,
        "x": 0.029,
        "y": 0.827
      },
      "kind": "source-note",
      "text": "1. As adjusted data gives effect to the repayment of the April 2021 Financing Debentures ($600,000 principal plus accrued interest), and the issuance and sale of Ordinary Shares in this offering, at an assumed public offering price of $3.15 per share, which is the minimum price at which we may issue Ordinary Shares until the approval of our Capital Reduction by the Grand Court of the Cayman Islands, after deducting underwriting discounts and commissions and estimated offering expenses, as if the sale of the Ordinary Shares had occurred on June 30, 2022.",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1ce09044-15be-4f0d-ac02-f1262104140d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.015,
        "w": 0.75,
        "x": 0.029,
        "y": 0.97
      },
      "kind": "source-note",
      "text": "3. Classified into ten classes, which vest upon a market capitalization ranging from $75,000,000 to $250,000,000.",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3ebbb462-71a4-4352-b8f2-87dcecd400fd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.93,
        "x": 0.029,
        "y": 0.899
      },
      "kind": "source-note",
      "text": "2. Gives pro forma effect for (i) the anticipated repayment in full of the April 2021 Financing Debentures with the proceeds from this offering by excluding 5,315 ordinary shares issuable upon conversion of the April 2021 Financing Debentures at a $140.00 per share conversion price, and (ii) includes 515,233 warrants to purchase ordinary shares at an exercise price of $1.94 per share, issuable conditioned upon the approval of our Capital Reduction by the Grand Court of the Cayman Islands.",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c5d75d35-aaa6-4be9-a853-ab62784a0820",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.41,
        "w": 0.45,
        "x": 0.505,
        "y": 0.22
      },
      "kind": "table",
      "text": "Pro Forma, Pre-Offering Cap Table Ordinary shares outstanding 1,963,768 Options (WAEP: $58.68) 132,421 Warrants (WAEP: $44.59) 1,246,448 Ordinary Shares issuable pursuant to performance rights³ 117,289 Fully Diluted Ordinary Shares Outstanding 3,459,926",
      "attrs": {},
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "06154519-46e4-415c-9a35-2bbecc27780e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.41,
        "w": 0.47,
        "x": 0.02,
        "y": 0.22
      },
      "kind": "table",
      "text": "Balance Sheet Data (As of June 30, 2022) Actual As Adjusted Cash and cash equivalents $1,509,000 $17,143,000 Total assets $10,278,000 $25,912,000 Long term debt $905,000 $905,000 Total shareholders' equity (deficit) $(1,240,000) $15,086,000",
      "attrs": {},
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3b205aa3-aac1-4014-80b8-72a07fda840d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.65,
        "x": 0.039,
        "y": 0.05
      },
      "kind": "title",
      "text": "Summary Balance Sheet and Cap Table",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f2757ce0-e785-448a-8ccd-5323ca4c7d5c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "fec4287b-bed6-429d-bcfb-8eb47dbbf1f0",
      "evidence": "The slide presents tables of financial data, including a balance sheet and cap table.",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}